← All indications
RNA Virus Infections
Diseases caused by RNA VIRUSES.
Subtype terms (17)
More specific conditions that are subtypes of RNA Virus Infections in the MeSH hierarchy.
- Arenaviridae Infections
- Astroviridae Infections
- Birnaviridae Infections
- Bunyaviridae Infections
- Caliciviridae Infections
9 drugs (2 approved, 7 experimental)
- Encephalitis, Arbovirus
- Flaviviridae Infections
6 drugs (3 approved, 3 experimental)
- Hemorrhagic Fevers, Viral
3 drugs (1 approved, 2 experimental)
- Hepatitis D
17 drugs (8 approved, 9 experimental)
- Hepatitis E
4 drugs (2 approved, 2 experimental)
- Mononegavirales Infections
5 drugs (2 approved, 3 experimental)
- Nidovirales Infections
4 drugs (3 approved, 1 experimental)
- Orthomyxoviridae Infections
5 drugs (1 approved, 4 experimental)
- Picornaviridae Infections
3 drugs experimental
- Reoviridae Infections
- Retroviridae Infections
5 drugs experimental
- Togaviridae Infections
1 drug experimental
Drugs by status
Phase 4 trials (2)
Phase 3 trials (9)
Phase 2 trials (15)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (26)
- PPD
- Merck
- Immune Design
- INC Research
- Lung Biotechnology PBC
- Biontech
- The EMMES Corporation
- FHI 360
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Institut National de la Santé Et de la Recherche Médicale, France
- McGill University
- inVentiv
- Centre de Recherche St-Louis, Quebec, Canada
- Topstone Research, Toronto, Canada
- Omnispec Clinical Research Inc, Mirabel, Canada
- Paradigm Research
- Broward Research Group
- Meridien Research
- Regional Clinical Research
- University of Montreal
- MRA Clinical Research
- Kendle International Inc.
- Leidos
- Assistance Publique - Hôpitaux de Paris
- Celularity, Inc.